BMO Capital lowered the firm’s price target on N-able (NABL) to $8.50 from $13.50 and keeps a Market Perform rating on the shares. The company reported a reasonable Q4, but the management’s FY25 revenue and adjusted EBITDA margin guide, inclusive of Adlumin, is weaker than expected, the analyst tells investors in a research note. N-able’s implied organic growth for next year is disappointing, partially due to ongoing annual contract initiative headwinds, though the firm is positive on Adlumin and the company’s opportunity in the security market more broadly, BMO added.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on NABL: